NANOCOR THERAPEUTICS
NanoCor Therapeutics is a biotechnology company founded to create a viable intracellular genetic protein therapy for the treatment of Chronic Heart Failure (CHF). The company was spun off from Asklêpios BioPharmaceutical, Inc. in November 2005. NanoCor’s initial focus is the commercial development of a non-invasive treatment for CHF. NanoCor’s therapeutic is comprised of the delivery of a proprietary gene developed at the Massachusetts General Hospital and the University of Cincinnati. The gene will be delivered with AskBio’s proprietary Biological NanoParticle (BNP™) and the Self-Complementary Vector technologies, which are derived from human adeno-associated virus vectors (rAAV).
NANOCOR THERAPEUTICS
Social Links:
Industry:
Biotechnology Genetics Therapeutics
Founded:
2005-01-01
Address:
Chapel Hill, North Carolina, United States
Country:
United States
Website Url:
http://www.nanocorthx.com
Total Employee:
1+
Status:
Active
Contact:
9199334755
Total Funding:
6.25 M USD
Technology used in webpage:
SPF SEDO DNS
Similar Organizations
Lannett Company
Lannett develops, manufactures, and distributes generic prescription pharmaceutical products in tablet.
Renova Therapeutics
Renova Therapeutics is an industry leader in the emerging field of gene therapy, pursuing the development of treatments.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Current Employees Featured
Founder
Investors List
Medtronic
Medtronic investment in Series B - NanoCor Therapeutics
Official Site Inspections
http://www.nanocorthx.com
- Host name: sv15112.xserver.jp
- IP address: 162.43.94.113
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
